XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements - Additional Information (Detail) (USD $)
3 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Sep. 30, 2014
Jun. 30, 2010
Dec. 31, 2012
Jan. 31, 2013
Fair Value Measurements Disclosure [Line Items]            
Short term investments $ 23,532,402us-gaap_MarketableSecuritiesCurrent   $ 21,653,032us-gaap_MarketableSecuritiesCurrent      
Investments 17,806,499us-gaap_MarketableSecuritiesNoncurrent   23,088,346us-gaap_MarketableSecuritiesNoncurrent      
Total investments 41,338,901us-gaap_MarketableSecurities   44,741,378us-gaap_MarketableSecurities      
Fair value of investment 40,759,068us-gaap_InvestmentsFairValueDisclosure   44,333,855us-gaap_InvestmentsFairValueDisclosure      
Warrants outstanding 1,437,011us-gaap_ClassOfWarrantOrRightOutstanding          
Non-cash gain (loss) from change in fair value of the derivative liability 2,179,651us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings (3,507,496)us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings        
Duration of exchange rights 7 years          
Ablaris Therapeutics            
Fair Value Measurements Disclosure [Line Items]            
Warrants outstanding 585,000us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
Non-cash gain (loss) from change in fair value of the derivative liability $ 202,491us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
$ (12,082)us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
       
Exchange right convertible conversion ratio for first year 0.06arwr_ExchangeRightConvertibleConversionRatioForFirstYear
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
Exchange right convertible conversion ratio for second year 0.04arwr_ExchangeRightConvertibleConversionRatioForTwoYear
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
Exchange right convertible conversion ratio for third year 0.03arwr_ExchangeRightConvertibleConversionRatioForThreeYear
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
Exchange right convertible conversion ratio for fourth year 0.02arwr_ExchangeRightConvertibleConversionRatioForFourYear
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
Exchange right convertible conversion ratio for fifth year and beyond 0.01arwr_ExchangeRightConvertibleConversionRatioForFiveYear
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
Number of exchange right sold 675,000arwr_NumberOfExchangeRightAreSold
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= arwr_AblarisTherapeuticsMember
         
2010 Warrants            
Fair Value Measurements Disclosure [Line Items]            
Warrants issued to acquire Common Stock       329,649arwr_WarrantsIssuedToAcquireCommonStock
/ us-gaap_ClassOfWarrantOrRightAxis
= arwr_TwoThousandTenWarrantMember
   
Warrants outstanding 24,324us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_ClassOfWarrantOrRightAxis
= arwr_TwoThousandTenWarrantMember
         
2012 Warrants            
Fair Value Measurements Disclosure [Line Items]            
Warrants issued to acquire Common Stock         912,543arwr_WarrantsIssuedToAcquireCommonStock
/ us-gaap_ClassOfWarrantOrRightAxis
= arwr_TwoThousandTwelveWarrantMember
 
Warrants outstanding 265,161us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_ClassOfWarrantOrRightAxis
= arwr_TwoThousandTwelveWarrantMember
         
2013 Warrants            
Fair Value Measurements Disclosure [Line Items]            
Warrants issued to acquire Common Stock           833,530arwr_WarrantsIssuedToAcquireCommonStock
/ us-gaap_ClassOfWarrantOrRightAxis
= arwr_TwoThousandThirteenWarrantMember
Warrants outstanding 12,123us-gaap_ClassOfWarrantOrRightOutstanding
/ us-gaap_ClassOfWarrantOrRightAxis
= arwr_TwoThousandThirteenWarrantMember